Clinical Distancing of Hospitalized Patients with Advanced Heart Failure and Cardiac Transplantation During COVID-19
Published in The Journal of Heart and Lung Transplantation
COVID-19 in a pediatric heart transplant recipient: Emergence of Donor Specific Antibodies
Published in The Journal of Heart and Lung Transplantation
Ethical Considerations regarding Heart and Lung Transplantation and Mechanical Circulatory Support during the COVID-19 P...
...Published in The Journal of Heart and Lung Transplantation
To understand the challenges for thoracic transplantation and mechanical circulatory support during the current COVID-19 pandemic, we propose separating the effects of the pandemic into 5 distinct stages from a healthcare system perspective. We discuss how the classical ethical principles of utility, justice and efficiency may need to be adapted, a...
COVID-19 and Transplant Research from China: an ethical dilemma
Published in The Journal of Heart and Lung Transplantation
COVID-19 PNEUMONIA IN A DUAL HEART-KIDNEY RECIPIENT
Published in The Journal of Heart and Lung Transplantation
Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: friend or foe ?
Published in The Journal of Heart and Lung Transplantation
COVID-19 in a lung transplant recipient
Published in The Journal of Heart and Lung Transplantation
Donor organ evaluation in the era of coronavirus disease 2019: A case of nosocomial infection
Published in The Journal of Heart and Lung Transplantation
Comment on “Epidemiological and clinical characteristics of heart transplant recipients during the 2019 coronavirus outb...
Published in The Journal of Heart and Lung Transplantation
Circulating Exosomes from Human Lung Transplant Recipients Having Respiratory Viral Infections Contain Nucleic Acids and...
Published in The Journal of Heart and Lung Transplantation
Purpose Exosomes are membrane bound vesicles are released by cells into body fluids. Our laboratory demonstrated the presence of circulating exosomes with lung self-antigens (Collagen-V and K-α Tubulin) and donor HLA in lung transplant recipients (LTxRs) undergoing rejection. Since respiratory viral infections (RVI) is a risk factor for development...
